DK0573601T3 - Behandling af cellulitis med retinoider - Google Patents

Behandling af cellulitis med retinoider

Info

Publication number
DK0573601T3
DK0573601T3 DK92908452T DK92908452T DK0573601T3 DK 0573601 T3 DK0573601 T3 DK 0573601T3 DK 92908452 T DK92908452 T DK 92908452T DK 92908452 T DK92908452 T DK 92908452T DK 0573601 T3 DK0573601 T3 DK 0573601T3
Authority
DK
Denmark
Prior art keywords
cellulitis
retinoids
treatment
amount
cellulite
Prior art date
Application number
DK92908452T
Other languages
Danish (da)
English (en)
Inventor
Albert M Kligman
Original Assignee
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albert M Kligman filed Critical Albert M Kligman
Application granted granted Critical
Publication of DK0573601T3 publication Critical patent/DK0573601T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92908452T 1991-02-27 1992-02-26 Behandling af cellulitis med retinoider DK0573601T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/661,753 US5051449A (en) 1991-02-27 1991-02-27 Treatment of cellulite with retinoids
PCT/US1992/001541 WO1992015293A1 (en) 1991-02-27 1992-02-26 Treatment of cellulite with retinoids

Publications (1)

Publication Number Publication Date
DK0573601T3 true DK0573601T3 (da) 1999-06-23

Family

ID=24654977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908452T DK0573601T3 (da) 1991-02-27 1992-02-26 Behandling af cellulitis med retinoider

Country Status (17)

Country Link
US (1) US5051449A (de)
EP (1) EP0573601B1 (de)
JP (1) JP2893483B2 (de)
KR (1) KR100224284B1 (de)
AT (1) ATE172113T1 (de)
AU (1) AU666303B2 (de)
CA (1) CA2104452C (de)
DE (1) DE69227306T2 (de)
DK (1) DK0573601T3 (de)
ES (1) ES2124725T3 (de)
FI (1) FI103950B1 (de)
HU (1) HU218914B (de)
IE (1) IE920624A1 (de)
NO (1) NO304727B1 (de)
NZ (1) NZ241757A (de)
SG (1) SG69981A1 (de)
WO (1) WO1992015293A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134163A (en) * 1989-09-01 1992-07-28 Kligman Albert M Methods of preventing and reducing the size of striae distensae lesions
US5521221A (en) * 1991-04-09 1996-05-28 Sloan-Kettering Institute For Cancer Research Retro-α-retinol (4,14-retro-retinol) derivatives and uses of retro-α-retinol
JP2765354B2 (ja) * 1992-03-09 1998-06-11 住友電装株式会社 接続具における電線の敷線方法
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
DE69531559D1 (de) * 1995-10-18 2003-09-25 Mary Kay Inc Topisch angewandte strukturelle behandlungen der zellulitis
EP0866693B1 (de) * 1995-10-18 2003-08-20 Mary Kay Inc. Topisch angewandte strukturelle behandlungen der zellulitis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
EP1720605A4 (de) * 2003-06-23 2007-10-24 Transpharma Medical Ltd Transdermales abgabesystem für kosmetische mittel
FR2863492B1 (fr) * 2003-12-10 2007-08-24 Oreal Utilisation des modulateurs d'aquaglyceroporines comme amincissant
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
US20070025950A1 (en) * 2005-07-28 2007-02-01 Elson Melvin L Composition and method for treating cellulite
WO2008025368A1 (en) * 2006-08-30 2008-03-06 Merck Patent Gmbh Use of chromen-4-one derivatives
DE602007002276D1 (de) 2007-03-20 2009-10-15 Zusammensetzung enthältend Retinoid und Beta-aminoisobuttersäurederivate
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
DE102010054149A1 (de) 2010-12-10 2012-06-14 Merck Patent Gmbh 2-Pyrone
BR112018008556A2 (pt) 2015-10-30 2018-10-23 Patagonia Pharmaceuticals Llc ?composições farmacêuticas e métodos para tratar ictiose congênita?

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4288633A (en) * 1980-04-03 1981-09-08 American Cyanamid Company 1-Hydroxymethyl-11-deoxy-16-hydroxy-prosten-1-ol-derivatives
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5070108A (en) * 1990-10-12 1991-12-03 Trustees Of The University Of Pennsylvania Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
MX9201084A (es) * 1991-04-15 1992-12-21 Bristol Myers Squibb Co Hiper pigmentacion de la piel

Also Published As

Publication number Publication date
JPH06507395A (ja) 1994-08-25
KR930702992A (ko) 1993-11-29
NO304727B1 (no) 1999-02-08
NZ241757A (en) 1994-04-27
CA2104452C (en) 2002-07-16
HU218914B (hu) 2000-12-28
FI933736L (fi) 1993-08-25
CA2104452A1 (en) 1992-08-28
DE69227306D1 (de) 1998-11-19
EP0573601A4 (de) 1994-01-12
FI103950B (fi) 1999-10-29
IE920624A1 (en) 1992-09-09
KR100224284B1 (ko) 1999-10-15
JP2893483B2 (ja) 1999-05-24
WO1992015293A1 (en) 1992-09-17
ES2124725T3 (es) 1999-02-16
SG69981A1 (en) 2000-01-25
AU666303B2 (en) 1996-02-08
FI933736A0 (fi) 1993-08-25
HUT65651A (en) 1994-07-28
DE69227306T2 (de) 1999-06-02
EP0573601B1 (de) 1998-10-14
ATE172113T1 (de) 1998-10-15
AU1644892A (en) 1992-10-06
NO932949L (no) 1993-08-19
EP0573601A1 (de) 1993-12-15
HU9302437D0 (en) 1993-11-29
NO932949D0 (no) 1993-08-19
US5051449A (en) 1991-09-24
FI103950B1 (fi) 1999-10-29

Similar Documents

Publication Publication Date Title
DK0573601T3 (da) Behandling af cellulitis med retinoider
DE69029804D1 (de) VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
DE69210515D1 (de) Kosmetisches Mittel
DE68917512D1 (de) Kosmetisches Präparat.
BR9704529A (pt) Emulsão de óleo-emágua cosmética e processo para reduzir a irritação ou sensação de picada causada pela aplicação tópica de uma composição contendo um hidroxiácido ou um retinóide
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
CA2144509A1 (en) Skin-conditioning composition, its application and manufacture
NO973900L (no) Nitrogenoksyd syntase inhibitor
CA2099188A1 (en) Use of a cosmetic composition
DE69628287D1 (de) Mittel zur behandlung lichtgeschädigter haut die einen rar-alpha antagonisten und ein multiselektives retinoid enthalten
NO920805L (no) Metoder for forhindring og redusering av stoerrelsen av striae distensae-lesjoner
DE69018570D1 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
DE68912227D1 (de) Behandlung von Periodontoklasie mit Retinsäure.
IL117991A0 (en) Treatment of actinic keratosis displastic nevi and other proliferative skin disorders with topical clotrimazole
IT1094967B (it) Composizione farmaceutica ad attivita'antiandrogena